Reuters logo
BRIEF-Theravance Biopharma's unit enters into fourth amendment with Pfizer
October 4, 2016 / 9:46 PM / a year ago

BRIEF-Theravance Biopharma's unit enters into fourth amendment with Pfizer

Oct 4 (Reuters) - Theravance Biopharma Inc

* Amendment extends term of agreement from its prior termination date of December 31, 2017 to December 31, 2020 - SEC filing

* On Sept. 29 its unit entered into fourth amendment to technology transfer,supply agreement with Pfizer Centreone Group of Pfizer Inc

* Theravance Biopharma Inc says amendment establishes new pricing terms and new minimum purchase requirements to be effective during additional term Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below